klei20151209_sc13da.htm

 

 

OMB APPROVAL

 

UNITED STATES

 OMB Number:                         3235-0145

 

SECURITIES AND EXCHANGE COMMISSION

 Expires:     

 

Washington, D.C. 20549

 Estimated average burden

 

 

 hours per response                          14.5

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

 

(Amendment No. 5)

 

 

Scientific Industries, Inc.

(Name of Issuer)

 

Common Stock, $0.05 par value per share

(Title of Class Securities)

 

808757108

(CUSIP Number)

 

Farrell Fritz, P.C.

1320 RXR Plaza
Uniondale, New York 11556

(516) 227-0633 

Attn: Alon Y. Kapen, Esq.

 

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications)

 

November 13, 2015

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

 

[Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.]

 

[* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.]

 

[The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).]

  

 

 

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

SEC 1746(3-06)

 

 
 

 

  

CUSIP No.      808757108     

 

1.

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

    Lowell A. Kleiman

 

2.

 

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)

 

(b)

 

3.

 

SEC Use Only

 

4.

 

Source of Funds (See Instructions)  OO

 

5.

 

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

6.

 

Citizenship or Place of Organization United States

 

 

 

 

Number of

 

7.     Sole Voting Power           60,000

Shares Bene-

 

ficially by

8.     Shared Voting Power           30,000

Owned by Each

 

Reporting

9.     Sole Dispositive Power           60,000

Person With

 
 

10.   Shared Dispositive Power           30,000

 

11.

 

Aggregate Amount Beneficially Owned by Each Reporting Person           90,000

 

12.

 

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see Instructions)

 

13.

 

Percent of Class Represented by Amount in Row (11)           6.04%

 

14.

 

Type of Reporting Person (See Instructions)

    IN

  

 
 

 

  

Item 1.

Security and Issuer

 

This Amendment No. 5 ("Amendment No. 5") amends and supplements the statements on Schedule 13D filed with the Securities and Exchange Commission on September 16, 1992 (the "Original Schedule 13D"), as amended on October 17, 2002, October 22, 2002, October 30, 2002, and January 8, 2015 (collectively with the Original Schedule 13D and this Amendment No. 5, the "Schedule 13D") with respect to the common stock, par value $0.05 per share (the “Common Stock”), of Scientific Industries, Inc., a Delaware corporation (the “Issuer”).  This Amendment No. 5 reflects a change in beneficial ownership of the Reporting Person by 1% or more, and also serves to correct a clerical error in Amendment No. 4, filed on January 8, 2015, relating to the number of shares beneficially owned by the Reporting Person with sole voting and dispositive power. Specifically, Amendment No. 4 inaccurately reported the number of shares beneficially owned by the Reporting Persons with sole voting and dispositive power as 110,600; the correct number of shares beneficially owned by the Reporting Person with sole voting and dispositive power was 110,690. The Statement is hereby amended to correct such inaccuracy.

 

Capitalized terms used herein and not otherwise defined in this Amendment No. 5 have the meanings set forth in the Original Schedule 13D. Only those items that are reported herein are amended, and only to the extent amended herein; all other items, including previously filed exhibits, remain unchanged and are incorporated by reference herein.

 

Item 2.

Identity and Background

 

(a) This Schedule 13D is filed by Lowell A. Kleiman (the "Reporting Person").

 

(b) The business address for the Reporting Person c/o Farrell Fritz, P.C., 1320 RXR Plaza, Uniondale, New York 11556.

 

(c) The Reporting Person is currently a private investor.

 

(d) During the past five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

 

(e) During the past five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, and is not subject to any judgment, decree or final order enjoining future violations of, prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws.

 

(f) The Reporting Person is a citizen of the United States of America.

 

Item 4.

Purpose of Transaction

 

Since the filing of the Original Schedule 13D, the Reporting Person has sold 49,581 shares of Common Stock in the ordinary course of his investment activities and not with any purpose of, or with the effect of, changing or influencing the control of the Issuer, or in connection with or as a participant in any transaction having that purpose or effect.  All of the information set forth in the responses Item 4 of the Original Schedule 13D otherwise remains in full force and effect and is incorporated by reference herein.

 

Item 5.

Interest in Securities of the Issuer

 

(a)            The Reporting Person owns beneficially in the aggregate 90,000 shares of Common Stock, constituting 6.04% of the shares outstanding based on 1,489,112 shares of Common Stock outstanding as of October 30, 2015.

 

(b)            The Reporting Person has sole power to vote and to dispose of the 60,000 shares of Common Stock owned by him.

 

(c)            The Reporting Person has shared power to vote and to dispose of the 30,000 shares of Common Stock owned by him and his wife, Priscilla H. Kleiman, as joint tenants with the right of survivorship.     

 

 
 

 

  

 

(i)

The business address for Priscilla H. Kleiman is c/o Farrell Fritz, P.C., 1320 RXR Plaza, Uniondale, New York 11556.

 

(ii)

Priscilla H. Kleiman is currently a private investor.

 

(iii)

During the past five years, Priscilla H. Kleiman has not been convicted in a criminal proceeding (excluding traffic violations of similar misdemeanors).

 

(iv)

During the past five years, the Priscilla H. Kleiman has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, and is not subject to any judgment, decree or final order enjoining future violations of, prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws.

 

(v)

Priscilla H. Kleiman is a citizen of the United States of America.

 

(d)  

Schedule A annexed hereto lists all transactions in the Securities by the Reporting Person since December 30, 2014.  All of such sales were effected in the open market.

 

SIGNATURE

 

After reasonable inquiry, and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

December 9, 2015                                                      

Date

 

 

/s/ Lowell A. Kleiman                                               

Signature

 

 

Lowell A. Kleiman                                                    

Name 

 

 
 

 

 

SCHEDULE A

 

Transactions in the Shares by the Reporting Person since December 30, 2014:

     

 

Shares Sold

100

Price Per Share ($)

$3.020

Date of Sale

1/6/15

100

$2.760

4/21/15

2,800

$2.625

4/21/15

100

$2.850

4/27/15

791

$2.800

4/30/15

100

900

1,000

300

500

2,500

2,500

2,500

2,500

1,000

1,500

1,500

2,000

2,000

2,000

2,000

1,500

1,200

1,190

$2.810

$2.800

$2.900

$2.760

$2.760

$2.700

$3.000

$2.500

$2.500

$2.700

$2.750

$2.650

$2.700

$2.710

$2.710

$2.680

$2.680

$2.700

$2.700

5/1/151

5/13/15

5/14/15

6/30/15

6/30/15

11/12/15

11/12/15

11/13/15

11/13/15

12/2/15

12/2/15

12/2/15

12/3/15

12/3/15

12/3/15

12/3/15

12/3/15

12/3/15

12/3/15

 


*  On May 4, 2015, the Reporting Person transferred a certificate of 50,690 shares from an account over which he has sole voting and dispositive power to an account in which he shares voting and dispositive power jointly with his wife, Priscilla H. Kleiman.